ConvaTec Group PLC (LON:CTEC) Receives GBX 306 Average Price Target from Analysts

Shares of ConvaTec Group PLC (LON:CTEC) have received an average rating of “Moderate Buy” from the nine research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is GBX 306.

CTEC has been the topic of several recent analyst reports. JPMorgan Chase & Co. lowered their target price on shares of ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating on the stock in a research note on Friday, May 22nd. Jefferies Financial Group restated a “buy” rating and issued a GBX 300 price target on shares of ConvaTec Group in a research note on Monday, June 8th. UBS Group reaffirmed a “buy” rating and issued a GBX 375 price target on shares of ConvaTec Group in a report on Monday, May 18th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 315 price target on shares of ConvaTec Group in a report on Wednesday, April 8th. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 340 price objective on shares of ConvaTec Group in a report on Tuesday, April 21st.

ConvaTec Group Stock Up 1.4%

CTEC stock opened at GBX 216.44 on Wednesday. ConvaTec Group has a one year low of GBX 193 and a one year high of GBX 259.30. The company has a debt-to-equity ratio of 99.96, a quick ratio of 0.96 and a current ratio of 1.53. The firm’s fifty day moving average is GBX 207.86 and its 200 day moving average is GBX 222.92. The firm has a market cap of £4.23 billion, a PE ratio of 25.17, a P/E/G ratio of 0.93 and a beta of 0.76.

Insider Buying and Selling at ConvaTec Group

In other ConvaTec Group news, insider Jonny Mason bought 50,000 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The shares were purchased at an average price of GBX 201 per share, for a total transaction of £100,500. 0.98% of the stock is currently owned by insiders.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.